|
1
|
Mobasheri A and Batt M: An update on the
pathophysiology of osteoarthritis. Ann Phys Rehabil Med.
59:333–339. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Roos EM and Arden NK: Strategies for the
prevention of knee osteoarthritis. Nat Rev Rheumatol. 12:92–101.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Radin EL, Paul IL and Rose RM: Role of
mechanical factors in pathogenesis of primary osteoarthritis.
Lancet. 1:519–522. 1972. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Carman WJ, Sowers M, Hawthorne VM and
Weissfeld LA: Obesity as a risk factor for osteoarthritis of the
hand and wrist: A prospective study. Am J Epidemiol. 139:119–129.
1994. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Poonpet T and Honsawek S: Adipokines:
Biomarkers for osteoarthritis? World J Orthop. 5:319–327. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang X, Hunter D, Xu J and Ding C:
Metabolic triggered inflammation in osteoarthritis. Osteoarthritis
Cartilage. 23:22–30. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ku JH, Lee CK, Joo BS, An BM, Choi SH,
Wang TH and Cho HL: Correlation of synovial fluid leptin
concentrations with the severity of osteoarthritis. Clin Rheumatol.
28:1431–1435. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lübbeke A, Finckh A, Puskas GJ, Suva D,
Lädermann A, Bas S, Fritschy D, Gabay C and Hoffmeyer P: Do
synovial leptin levels correlate with pain in end stage arthritis?
Int Orthop. 37:2071–2079. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Otero M, Reino JJ Gomez and Gualillo O:
Synergistic induction of nitric oxide synthase type II: In vitro
effect of leptin and interferon-gamma in human chondrocytes and
ATDC5 chondrogenic cells. Arthritis Rheum. 48:404–409. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Otero M, Lago R, Lago F, Reino JJ and
Gualillo O: Signalling pathway involved in nitric oxide synthase
type II activation in chondrocytes: Synergistic effect of leptin
with interleukin-1. Arthritis Res Ther. 7:R581–R591. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yaykasli KO, Hatipoglu OF, Yaykasli E,
Yildirim K, Kaya E, Ozsahin M, Uslu M and Gunduz E: Leptin induces
ADAMTS-4, ADAMTS-5, and ADAMTS-9 genes expression by
mitogen-activated protein kinases and NF-κB signaling pathways in
human chondrocytes. Cell Biol Int. 39:104–112. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lam QL and Lu L: Role of leptin in
immunity. Cell Mol Immunol. 4:1–13. 2007.PubMed/NCBI
|
|
13
|
Scotece M and Mobasheri A: Leptin in
osteoarthritis: Focus on articular cartilage and chondrocytes. Life
Sci. 140:75–78. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hida K, Wada J, Eguchi J, Zhang H, Baba M,
Seida A, Hashimoto I, Okada T, Yasuhara A, Nakatsuka A, et al:
Visceral adipose tissue-derived serine protease inhibitor: A unique
insulin-sensitizing adipocytokine in obesity. Proc Natl Acad Sci
USA. 102:10610–10615. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Seeger J, Ziegelmeier M, Bachmann A,
Lössner U, Kratzsch J, Blüher M, Stumvoll M and Fasshauer M: Serum
levels of the adipokine vaspin in relation to metabolic andrenal
parameters. J Clin Endocrinol Metab. 93:247–251. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tan BK, Heutling D, Chen J, Farhatullah S,
Adya R, Keay SD, Kennedy CR, Lehnert H and Randeva HS: Metformin
decreases the adipokine vaspin in overweight women with polycystic
ovary syndrome concomitant with improvement in insulin sensitivity
and a decrease in insulin resistance. Diabetes. 57:1501–1507. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Caminos JE, Bravo SB, Garcés MF, González
CR, Cepeda LA, González AC, Nogueiras R, Gallego R,
García-Caballero T, Cordido F, et al: Vaspinand amylin are
expressed in human and rat placenta and regulated by nutritional
status. Histol Histopathol. 24:979–990. 2009.PubMed/NCBI
|
|
18
|
Blüher M: Vaspin in obesity and diabetes:
Pathophysiological and clinical significance. Endocrine.
41:176–182. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Senolt L, Polanská M, Filková M, Cerezo
LA, Pavelka K, Gay S, Haluzík M and Vencovsky J: Vaspin and
omentin: New adipokines differentially regulated at the site of
inflammation in rheumatoid arthritis. Ann Rheum Dis. 69:1410–1411.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Maijer KI, Neumann E, Müller-Ladner U,
Drop DA, Ramwadhdoebe TH, Choi IY, Gerlag DM, de Hair MJ and Tak
PP: Serum Vaspin Levels Are Associated with the Development of
Clinically Manifest Arthritis in Autoantibody-Positive Individuals.
PLoS One. 10:e01449322015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bao JP, Jiang LF, Chen WP, Hu PF and Wu
LD: Expression of vaspin in the joint and the levels in the serum
and synovial fluid of patients with osteoarthritis. Int J Clin Exp
Med. 7:3447–3453. 2014.PubMed/NCBI
|
|
22
|
Bao JP, Jiang LF, Li J, Chen WP, Hu PF and
Wu LD: Visceral adipose tissue-derived serine protease inhibitor
inhibits interleukin-1β-induced catabolic and inflammatory
responses in murine chondrocytes. Mol Med Rep. 10:2191–2197.
2014.PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Dozio E, Corsi MM, Ruscica M, Passafaro L,
Steffani L, Banfi G and Magni P: Adipokine actions on cartilage
homeostasis. Adv Clin Chem. 55:61–79. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hutcheson J: Adipokines influence the
inflammatory balance in autoimmunity. Cytokine. 75:272–279. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang Y, Proenca R, Maffei M, Barone M,
Leopold L and Friedman JM: Positional cloning of the mouse obese
gene and its human homologue. Nature. 372:425–432. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Toussirot É, Michel F, Binda D and
Dumoulin G: The role of leptin in thepathophysiology of rheumatoid
arthritis. Life Sci. 140:29–36. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bao JP, Chen WP, Feng J, Hu PF, Shi ZL and
Wu LD: Leptin plays a catabolic role on articular cartilage. Mol
Biol Rep. 37:3265–3272. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wada J: Vaspin: A novel serpin with
insulin-sensitizing effects. Expert Opin Investig Drugs.
17:327–333. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Li H, Peng W, Zhuang J, Lu Y, Jian W, Wei
Y, Li W and Xu Y: Vaspin attenuates high glucose-induced vascular
smooth muscle cells proliferation and chemokinesis by inhibiting
the MAPK, PI3K/Akt and NF-κB signaling pathways. Atherosclerosis.
228:61–68. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Jung CH, Lee MJ, Kang YM, Lee YL, Yoon HK,
Kang SW, Lee WJ and Park JY: Vaspin inhibits cytokine-induced
nuclear factor-kappa B activation and adhesion molecule expression
via AMP-activated protein kinase activation in vascular endothelial
cells. Cardiovasc Diabetol. 13:412014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kukla M, Mazur W, Buldak RJ and
Zwirska-Korczala K: Potential role of leptin, adiponectin and three
novel adipokines-visfatin, chemerin and vaspin-in chronic
hepatitis. Mol Med. 17:1397–1410. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ghilardi N and Skoda RC: The leptin
receptor activates janus kinase 2 and signals for proliferation in
a factor-dependent cell line. Mol Endocrinol. 11:393–399. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Sinha MK, Sturis J, Ohannesian J, Magosin
S, Stephens T, Heiman ML, Polonsky KS and Caro JF: Ultradian
oscillations of leptin secretion in humans. Biochem Biophys Res
Commun. 228:733–738. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Song RH, Tortorella MD, Malfait AM, Alston
JT, Yang Z, Arner EC and Griggs DW: Aggrecan degradation in human
articular cartilage explants is mediated by both ADAMTS-4 and
ADAMTS-5. Arthritis Rheum. 56:575–585. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lipari L and Gerbino A: Expression of
gelatinases (MMP-2, MMP-9) in humanarticular cartilage. Int J
Immunopathol Pharmacol. 26:817–823. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Pelletier JP, Martel-Pelletier J and
Abramson SB: Osteoarthritis, an inflammatory disease: Potential
implication for the selection of new therapeutic targets. Arthritis
Rheum. 44:1237–1247. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Murrell GA, Jang D and Williams RJ: Nitric
oxide activates metalloprotease enzymes in articular cartilage.
Biochem Biophys Res Commun. 206:15–21. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Miller RE, Miller RJ and Malfait AM:
Osteoarthritis joint pain: The cytokine connection. Cytokine.
70:185–193. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Blasioli DJ and Kaplan DL: The roles of
catabolic factors in the development of osteoarthritis. Tissue Eng
Part B Rev. 20:355–363. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Goldring MB and Otero M: Inflammation in
osteoarthritis. Curr Opin Rheumatol. 23:471–478. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Marcu KB, Otero M, Olivotto E, Borzi RM
and Goldring MB: NF-kappaB signaling: Multiple angles to target OA.
Curr Drug Targets. 11:599–613. 2010. View Article : Google Scholar : PubMed/NCBI
|
